Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is effective in adults with active Crohn disease.

Charissa van Zwol-Janssens, M.D., from the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted an exploratory cross-sectional observational study to examine associations between ...